Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 8.38
  • 0.23  -2.67%
    Today's Change
  • 8.61
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 4/22/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding42 million
Market Cap$352 million
Return on Equity ttm-202.72%
Last DividendSUPN:US does not pay a dividend
EPS: Year Actual ttm-2.208
EPS: Year Est. 12/14 ttm-0.740
EPS: Quarterly Actual 12/13 -0.65
EPS: Quarterly Est. 3/14 -0.42
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-6.62
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$12 million
Net Income$-92 million
Total Assets$111 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!